TFC Financial Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$23.3K Hold
211
– – ﹤0.01% 365
2026
Q2
$16.5K Hold
211
– – ﹤0.01% 387
2026
Q1
$13.6K Hold
211
– – ﹤0.01% 386
2025
Q4
$14.2K Buy
211
+1
+0.5% +$67 ﹤0.01% 370
2025
Q3
$15.4K Buy
210
+33
+19% +$2.19K ﹤0.01% 370
2025
Q2
$9.21K Sell
177
-1
-0.6% -$57 ﹤0.01% 384
2025
Q1
$11.4K Buy
178
+41
+30% +$2.38K ﹤0.01% 355
2024
Q4
$6.55K Buy
137
+43
+46% +$2.2K ﹤0.01% 388
2024
Q3
$5.38K Buy
+94
New +$5.39K ﹤0.01% 409

Other funds holding HALO

TFC Financial Management's HALO Position: Q3 2026 in Review

TFC Financial Management held its Halozyme (HALO) position steady in Q3 2026 at 211 shares worth $23.3K. The position accounts for ﹤0.01% of the portfolio, ranked #365.

TFC Financial Management first reported a position in HALO in Q3 2024 and has held it in 9 quarters since. 777 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • TFC Financial Management held 211 shares of Halozyme worth $23.3K as of Q3 2026.
  • TFC Financial Management left its Halozyme share count unchanged in Q3 2026.
  • Halozyme made up ﹤0.01% of TFC Financial Management's portfolio in Q3 2026, its #365 holding.
  • TFC Financial Management first reported a position in Halozyme in Q3 2024 and has held it in 9 quarters since.
  • 777 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on TFC Financial Management's 13F filing for Q3 2026, filed 26 Oct 2026.